Literature DB >> 33926942

How SARS-CoV-2 first adapted in humans.

Hyeryun Choe1, Michael Farzan1.   

Abstract

Entities:  

Year:  2021        PMID: 33926942     DOI: 10.1126/science.abi4711

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


× No keyword cloud information.
  6 in total

1.  Mathematical analysis and topology of SARS-CoV-2, bonding with cells and unbonding.

Authors:  Arni S R Srinivasa Rao; Steven G Krantz
Journal:  J Math Anal Appl       Date:  2021-09-14       Impact factor: 1.417

Review 2.  The Role of Antibodies in the Treatment of SARS-CoV-2 Virus Infection, and Evaluating Their Contribution to Antibody-Dependent Enhancement of Infection.

Authors:  Mohammed A H Farouq; Reinaldo Acevedo; Valerie A Ferro; Paul A Mulheran; Mohammed M Al Qaraghuli
Journal:  Int J Mol Sci       Date:  2022-05-28       Impact factor: 6.208

3.  Comparative structural analyses of selected spike protein-RBD mutations in SARS-CoV-2 lineages.

Authors:  Urmi Roy
Journal:  Immunol Res       Date:  2021-11-16       Impact factor: 4.505

4.  Phage Display-Derived Compounds Displace hACE2 from Its Complex with SARS-CoV-2 Spike Protein.

Authors:  Marc Sevenich; Elena Thul; Nils-Alexander Lakomek; Thomas Klünemann; Maren Schubert; Federico Bertoglio; Joop van den Heuvel; Patrick Petzsch; Jeannine Mohrlüder; Dieter Willbold
Journal:  Biomedicines       Date:  2022-02-14

5.  Neutralization of SARS-CoV-2 Variants of Concern Harboring Q677H.

Authors:  Cong Zeng; John P Evans; Julia N Faraone; Panke Qu; Yi-Min Zheng; Linda Saif; Eugene M Oltz; Gerard Lozanski; Richard J Gumina; Shan-Lu Liu
Journal:  mBio       Date:  2021-10-05       Impact factor: 7.867

6.  Dynamics of SARS-CoV-2 Spike Proteins in Cell Entry: Control Elements in the Amino-Terminal Domains.

Authors:  Enya Qing; Tom Kicmal; Binod Kumar; Grant M Hawkins; Emily Timm; Stanley Perlman; Tom Gallagher
Journal:  mBio       Date:  2021-08-03       Impact factor: 7.867

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.